Prostamax is a synthetic Khavinson peptide bioregulator (often identified as a Lys-Glu-Asp-Pro amino acid sequence) designed to target and support prostate tissue health. In preliminary animal models and laboratory settings, it demonstrates several distinct tissue-specific benefits:
Reduces Prostate Inflammation: It helps alleviate symptoms of chronic aseptic prostatitis by significantly decreasing tissue swelling (edema), blood vessel congestion (hyperemia), and lymphoid infiltration.
Prevents Tissue Scarring and Atrophy: Research shows that the peptide helps halt pathological remodeling, effectively blocking the development of sclerotic (scarring) and atrophic processes in the prostate gland.
Regulates Immune Cell Activity: Prostamax impacts lymphocyte function by encouraging chromatin decondensation, which “unpacks” DNA to optimize gene expression and promote a calmer, more balanced immune response.
Protects Cellular Aging: By allowing older cells to more easily access packed DNA structures, the peptide supports protein synthesis, cellular repair, and reduces premature cell death.
Improves Urinary and Sexual Function: Animal models indicate a marked reduction in localized congestion, which translates to better overall urinary tract comfort and enhanced mating activity